We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Badalona Major Depressive Disorder Database Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01446692
First Posted: October 5, 2011
Last Update Posted: January 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
AstraZeneca
September 28, 2011
October 5, 2011
January 12, 2012
November 2011
Not Provided
Description of the antidepressant strategies switches [ Time Frame: 18 months ]
Number and type of treatment changes including combination, switch, or augmentation strategies.
Same as current
Complete list of historical versions of study NCT01446692 on ClinicalTrials.gov Archive Site
  • Health care resource utilization [ Time Frame: 18 months ]
  • Health care costs [ Time Frame: 18 months ]
  • Hamilton Depression Rating Scale [ Time Frame: 18 months ]
  • Medication possession rate to evaluate adherence [ Time Frame: 18 months ]
  • Referral to psychiatrist office [ Time Frame: 18 months ]
Same as current
Not Provided
Not Provided
 
Badalona Major Depressive Disorder Database Study
Therapeutic Strategies for the Management of Patients With Major Depressive Disorder (MDD) and Suboptimal Response to Antidepressant Drugs in Primary Care: the Badalona Database Study
A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care
Therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care: the Badalona database study
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Primary care clinic
Major Depressive Disorder
Not Provided
  • Patients with suboptimal response
  • Patients with symptomatic remission
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2260
January 2012
Not Provided

Inclusion Criteria:

  • An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD)
  • At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009
  • 18 months of enrollment with medical and pharmacy records after index episode date
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
 
NCT01446692
NIS-NES-XXX-2011/2
No
Not Provided
Not Provided
AstraZeneca
AstraZeneca
Not Provided
Not Provided
AstraZeneca
January 2012